Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Wyndham Worldwide Q1 Profit Falls But Adjusted Earnings Tops Street

RELATED NEWS
Trade WYN now with 

Hospitality services and products provider Wyndham Worldwide Corporation (WYN: Quote) Wednesday posted lower profit for the first quarter reflecting increased expenses. However, adjusted earnings surpassed the Street estimates.

For the three-month period, the company posted net income attributable to shareholders of $27 million versus prior-year earnings of $32 million. On a per share basis, earnings for the period fell to $0.19 from $0.21 last year.

On an adjusted basis, the firm posted earnings of $0.71 for the period. Nine analysts on average polled by Thomson Reuters estimated earnings per share of $0.67 for the quarter. Analysts estimates typically exclude one-time items.

Net revenue for the quarter climbed to $1.133 billion from $1.036 billion a year earlier and was in line with consensus estimate of $1.13 billion.

Early extinguishment of debt cost the company $111 million this year as opposed to $ 106 million last year.

Looking forward, the company sees adjusted earnings per share of approximately $3.60 to $3.70 and revenue of approximately $4.925 to $5.100 billion for the full fiscal year. Analysts are currently looking for earnings of $3.67 on revenue of $4.95 billion.

Click here to receive FREE breaking news email alerts for Wyndham Worldwide and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Proctor and Gamble (PG) has sold two of its soap brands to European consumer products giant Unilever (UN). Cincinnati-based P&G says the sale includes the global Camay brand, the Zest brand outside of North America and its Talisman manufacturing plant in Mexico. The plant employs approximately... Dish Network is no longer carrying Fox News in yet another dispute for the television provider. Fox News, which changed the face of cable news with its ardent advocacy of conservative issues, went dark Sunday, replaced on Dish by The Blaze, Glen Beck's new right-leaning channel. Fox Business channel... Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.